Aratana Therapeutics (PETX) Misses Q1 EPS by 10c
Get Alerts PETX Hot Sheet
Join SI Premium – FREE
Aratana Therapeutics (NASDAQ: PETX) reported Q1 EPS of ($0.52), $0.10 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $172 thousand versus the consensus estimate of $140 thousand.
For earnings history and earnings-related data on Aratana Therapeutics (PETX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- Methanex (MEOH) Tops Q1 EPS by 35c
- Universal Health Realty (UHT) Reports Q1 EPS of $0.38
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!